Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated smad1/5-smad3 complexes

Molecular and Cellular Biology

Volumn 32, Issue 14, 2012, Pages 2904-2916

  Grönroos, Eva ^a   Kingston, Isabel J ^a   Ramachandran, Anassuya ^a   Randall, Rebecca A ^a   Vizán, Pedro ^a   Hill, Caroline S ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; SMAD1 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; MULTIPROTEIN COMPLEXES; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864020480     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00231-12     Document Type: Article

References (56)

1. Agricola E, Randall RA, Gaarenstroom T, Dupont S, Hill CS. 2011. Recruitment of TIF1γ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol. Cell 43:85-96.
2. Alarcón C, et al. 2009. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 139:757-769.
3. Alarmo EL, et al. 2009. BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett. 275:35- 43.
4. Ashcroft GS, et al. 1999. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1:260 -266.
5. BabuRajendran N, et al. 2010. Structure of Smad1 MH1/DNA complex reveals distinctive rearrangements of BMP and TGF-β effectors. Nucleic Acids Res. 38:3477-3488.
6. Bharathy S, Xie W, Yingling JM, Reiss M. 2008. Cancer-associated transforming growth factor β type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype. Cancer Res. 68:1656 -1666.
7. Blobe GC, Schiemann WP, Lodish HF. 2000. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342:1350 -1358.
8. Candia AF, et al. 1997. Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development 124:4467- 4480.
9. Daly AC, Randall RA, Hill CS. 2008. Transforming growth factor β-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28:6889-6902.
10. Daly AC, Vizan P, Hill CS. 2010. Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses. J. Biol. Chem. 285:6489-6497.
11. Dennler S, et al. 1998. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091-3100.
12. Dorey K, Hill CS. 2006. A novel Cripto-related protein reveals an essential role for EGF-CFCs in Nodal signalling in Xenopus embryos. Dev. Biol. 292:303-316.
13. Ebisawa T, et al. 2001. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276:12477-12480.
14. Feng XH, Derynck R. 2005. Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21:659-693.
15. Galvin KE, Travis ED, Yee D, Magnuson T, Vivian JL. 2010. Nodal signaling regulates the bone morphogenic protein pluripotency pathway in mouse embryonic stem cells. J. Biol. Chem. 285:19747-19756.
16. Gao S, Laughon A. 2006. Decapentaplegic-responsive silencers contain overlapping mad-binding sites. J. Biol. Chem. 281:25781-25790.
17. Gentleman RC, et al. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80.
18. Germain S, Howell M, Esslemont GM, Hill CS. 2000. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev. 14:435- 451.
19. Goumans MJ, Mummery C. 2000. Functional analysis of the TGFβ receptor/ Smad pathway through gene ablation in mice. Int. J. Dev. Biol. 44:253-265.
20. Goumans MJ, et al. 2002. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21:1743-1753.
21. Iavarone A, Lasorella A. 2006. ID proteins as targets in cancer and tools in neurobiology. Trends Mol. Med. 12:588 -594.
22. Inman GJ, Hill CS. 2002. Stoichiometry of active Smad-transcription factor complexes on DNA. J. Biol. Chem. 277:51008 -51016.
23. Inman GJ, et al. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62:65-74.
24. Irizarry RA, et al. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e15.
25. Jones S, et al. 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806.
26. Kang Y, Chen CR, Massagué J. 2003. A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11:915-926.
27. Kavsak P, et al. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol. Cell 6:1365- 1375.
28. Kawakatsu M, et al. 2011. Loss of Smad3 gives rise to poor soft callus formation and accelerates early fracture healing. Exp. Mol. Pathol. 90: 107-115.
29. Korchynskyi O, ten Dijke P. 2002. Identification and functional characterization of distinct critically important bone morphogenetic proteinspecific response elements in the Id1 promoter. J. Biol. Chem. 277:4883- 4891.
30. Leary RJ, et al. 2008. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc. Natl. Acad. Sci. U. S. A. 105:16224 -16229.
31. Levy L, Hill CS. 2006. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17:41-58.
32. Levy L, et al. 2007. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol. Cell. Biol. 27: 6068-6083.
33. Liu IM, et al. 2009. TGFβ-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFβ switch. EMBO J. 28:88 -98.
34. Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL. 1998. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273:25628 -25636.
35. Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K. 2004. Endogenous TGF-β signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J. 23:552-563.
36. Massagué J. 2008. TGFβ in cancer. Cell 134:215-230.
37. Massagué J, Blain SW, Lo RS. 2000. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
38. Nakahiro T, Kurooka H, Mori K, Sano K, Yokota Y. 2010. Identification of BMP-responsive elements in the mouse Id2 gene. Biochem. Biophys. Res. Commun. 399:416-421.
39. Nicolás FJ, Hill CS. 2003. Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest. Oncogene 22:3698 -3711.
40. Ramel M-C, Hill CS. Spatial regulation of BMP activity. FEBS Lett., in press.
41. Rosen V. 2009. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev. 20:475- 480.
42. Ross S, Hill CS. 2008. How the Smads regulate transcription. Int. J. Biochem. Cell Biol. 40:383- 408.
43. Schmierer B, Hill CS. 2007. TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8:970 -982.
44. Schreiber E, Matthias P, Muller MM, Schaffner W. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
45. Shi W, et al. 2004. GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor. J. Cell Biol. 164:291-300.
46. Shi Y, Massagué J. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700.
47. Shi Y, et al. 1998. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell 94:585-594.
48. Smyth GK. 2005. Limma: linear models for microarray data, p 397-420. In Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (ed), Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, NY.
49. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3.
50. Wong C, et al. 1999. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor β Mol. Cell. Biol. 19:1821-1830.
51. Wrighton KH, Lin X, Yu PB, Feng XH. 2009. Transforming growth factor β can stimulate Smad1 phosphorylation independently of bone morphogenic protein receptors. J. Biol. Chem. 284:9755-9763.
52. Wu MY, Hill CS. 2009. TGF-β superfamily signaling in embryonic development and homeostasis. Dev. Cell 16:329 -343.
53. Wu MY, Ramel M-C, Howell M, Hill CS. 2011. SNW1 is a critical regulator of spatial BMP activity, neural plate border formation and neural crest specification in vertebrate embryos. PLoS Biol. 9:e1000593.
54. Xiao L, Yuan X, Sharkis SJ. 2006. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24:1476 -1486.
55. Yeo C, Whitman M. 2001. Nodal signals to Smads through Criptodependent and Cripto-independent mechanisms. Mol. Cell 7:949 -957.
56. Zawel L, et al. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611- 617.